Boc-L-norvaline

CAS: 53308-95-5

Ref. 3D-FB47086

Produktinformation

• Name: Boc-L-norvaline
• Synonyme: Boc-L-Nva-OHBoc-L-2-aminovaleric acid, N-(tert-butoxycarbonyl)norvaline, (2S)-2-[(tert-butoxycarbonyl)amino]pentanoate, Boc-Norvaline, Boc-Nva-OH・DCHA, Boc-Nva-OH (syrup), Boc-Nva-OH

Beschreibung

Boc-L-norvaline is a synthetic peptide that has been shown to have anticancer efficacy in animals. It binds to the same receptor as norvaline, which is an amide with a similar structure. Boc-L-norvaline was synthesized by attaching an L-amino acid to the N-terminus of norvaline, and has been shown to inhibit cancer cell growth in vitro and in vivo. This drug also has anti-bacterial properties, such as inhibiting the growth of Mycobacterium tuberculosis and Mycobacterium avium complex. Boc-L-norvaline inhibits bacterial growth by binding to DNA dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch clamp technique on human erythrocytes. This active form is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 217.26 g/mol
• Formel: C₁₀H₁₉NO₄
• Reinheit: Min. 95%